Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
8.08
-0.05 (-0.62%)
At close: Apr 28, 2026, 4:00 PM EDT
8.18
+0.10 (1.18%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Instil Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Selling, General & Admin
27.2244.2147.5569.3451.31
Upgrade
Research & Development
25.6915.7542.99136.83103.96
Upgrade
Operating Expenses
52.9159.9690.54206.17155.27
Upgrade
Operating Income
-52.91-59.96-90.54-206.17-155.27
Upgrade
Interest Expense
-5.83-8.99-5.21-1.88-
Upgrade
Interest & Investment Income
3.866.998.873.660.08
Upgrade
Other Non Operating Income (Expenses)
9.181.41-0.58-0.56-1.28
Upgrade
EBT Excluding Unusual Items
-45.7-60.55-87.46-204.96-156.46
Upgrade
Merger & Restructuring Charges
-16.62-7.49-72.01-5.43-
Upgrade
Impairment of Goodwill
----5.7-
Upgrade
Asset Writedown
----1.93-
Upgrade
Other Unusual Items
0.953.913.382.88-0.29
Upgrade
Pretax Income
-71.37-74.14-156.09-225.25-156.76
Upgrade
Income Tax Expense
----2.070.04
Upgrade
Net Income
-71.37-74.14-156.09-223.18-156.79
Upgrade
Net Income to Common
-71.37-74.14-156.09-223.18-156.79
Upgrade
Shares Outstanding (Basic)
77765
Upgrade
Shares Outstanding (Diluted)
77765
Upgrade
Shares Change (YoY)
2.43%0.10%0.44%22.19%562.55%
Upgrade
EPS (Basic)
-10.70-11.39-24.00-34.46-29.59
Upgrade
EPS (Diluted)
-10.70-11.39-24.00-34.46-29.59
Upgrade
Free Cash Flow
-36.62-55.7-102.69-264.75-179.97
Upgrade
Free Cash Flow Per Share
-5.49-8.55-15.79-40.88-33.96
Upgrade
EBITDA
-52.37-56.35-85.79-200.18-152.51
Upgrade
D&A For EBITDA
0.533.614.765.992.75
Upgrade
EBIT
-52.91-59.96-90.54-206.17-155.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.